Evolution of symptoms after ustekinumab induction therapy in patients with Crohn’s disease

By sjmartinez • July 2, 2023

Colombel JF, Sands BE, Gasink C, Yeager B, Adedokun OJ, Izanec J, Ma T, Gao LL, Lee SD, Targan SR, Ghosh S, Hanauer SB, Sandborn WJ. Evolution of symptoms after ustekinumab induction therapy in patients with Crohn's disease. Clin Gastroenterol Hepatol. 2023 Jun 28:S1542-3565(23)00499-8. doi: 10.1016/j.cgh.2023.06.014. Epub ahead of print. PMID: 37391056.

Tags: Cedars Sinai DoM, Crohn’s disease, Digestive Diseases, efficacy dynamics, Publications, remission, response, ustekinumab

Related Posts

Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery: The nuMoM2b Heart Health Study

Freaney PM, Huang X, Petito LC, Grobman WA, Catov J, Hauspurg A, Bairey Merz CN, Bello N, Kim JK, Lane A, Haas DM, Levine LD,[...]

Effectiveness of mailed versus in-person PAP initiation in VA’s TeleSleep program

Gomez A, Sarmiento KF, Smith C, Mitchell M, Lee D, Totten A, Sanders E, Ryden AM, Seo J, Bhattacharyya S, Harris B, Mempin R, Moghtaderi[...]

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

Bandos H, Kim S, Henry NL, Hays RD, Calsavara VF, Luu M, Gresham G, Lu KY, Irvin WJ, Suga JM, Siddique S, Cecchini RS, Rogatko[...]